Framingham, Mass.
Sanofi Genzyme is expanding its presence in the Framingham Technology Park in Massachusetts where its $80 million, 72,000-sf biomanufacturing facility is currently under construction. A two-story, 14,821-sf addition to the project will enable Sanofi Genzyme to increase its production capacity for advanced therapeutics.
